Downregulation of antigen-presenting cell functions after administration of mitogenic anti-CD3 monoclonal antibodies in mice

Blood

Volumn 94, Issue 12, 1999, Pages 4347-4357

  Muraille, Eric ^b   Andris, Fabienne ^b   Pajak, Bernard ^b   Wissing, K Martin ^b   De Smedt, Thibaut ^b   Desalle, Fabrice ^b   Goldman, Michel ^b   Alegre, Maria Luisa ^b   Urbain, Jacques ^b   Moser, Muriel ^b   Leo, Oberdan ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN D; MONOCLONAL ANTIBODY CD3;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; FEMALE; HYBRIDOMA; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

EID: 13044283432     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.12.4347     Document Type: Article

References (52)

1. Hart DNJ: Dendritic cells: Unique leukocyte populations which control the primary immune response. Blood 90:3245, 1997
2. Bancherau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392:245, 1998
3. Inaba K, Witmer-Pack M, Inaba M, Hathcoc KS, Sakuta H, Azuma M, Yagita H, Okumura K, Linsley PS, Ikehara S: The tissue distribution of the B7-2 costimulator in mice: Abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 180:1849, 1994
4. Moser M, De Smedt T, Sonnasse T, Tielemans F, Chentoufi AA, Muraille E, Van Mechelen M, Urbain J, Leo O: Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur J Immunol 25:2818, 1995
5. De Smedt T, Pajak B, Muraille E, Lespagnard L, Heinen E, De Batselier P, Urbain J, Leo O, Moser M: Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 184:1413, 1996
6. Hart DNJ, Fabre JW: Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues but not brain. J Exp Med 153:347, 1981
7. Larsen CP, Morris PJ, Austyn JM: Migration of dendritic leukocytes from cardiac allograft into host spleens. J Exp Med 171:307, 1990
8. Larsen CP, Steinman RM, Witmer-Pack M, Haskins DF, Morris PJ, Austyn JM: Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 172:1483, 1990
9. McKenzie JL, Beard ME, Hart DN: The effect of donor pretreatment on interstitial dendritic cell content and rat cardiac allograft survival. Transplantation 38:371, 1984
10. McKenzie JL, Beard ME, Hart DN: Depletion of donor kidney dendritic cells prolongs graft survival. Transplant Proc 16:948, 1984
11. Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer P: Localisation of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. J Exp Med 166:1654, 1987
12. Roake JA, Rao AS, Morris PJ, Larsen CP, Hankins DF, Austyn JM: Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor and interleukin 1. J Exp Med 181:2237, 1995
13. Ortho Multicenter Transplant Study Group: A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N Engl J Med 313:337, 1985
14. Abramowicz D, Goldman M, De Pauw L, Vanherweghem JL, Kinnaert P, Vereerstraeten P: The long term effects of prophylactic OKT3 monoclonal antibody in cadaver kidney transplantation: A single-center, prospective, randomized study. Transplantation 54:433, 1992
15. Opelz G: Efficacy of rejection prophylaxis with OKT3 in renal transplantation. Transplantation 60:1220, 1995
16. Abramowicz D, Schandene L, Goldman M: Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation 47:606, 1989
17. Chatenoud L, Ferran C, Bach J-F: The anti-CD3-induced syndrome: A consequence of massive in vivo cell activation. Curr Top Microbiol Immunol 174:121, 1991
18. Haskins K, Kubo R, White J, Pigeon M, Kappler J, Marrack P: The major histocompatibility complex-restricted antigen receptor on T cells. J Exp Med 157:1149, 1983
19. Schwartz RH, Fox BS, Fraga E, Chen C, Singh B: The T lymphocyte response to cytochrome c. V. Determination of the minimal peptide size required for stimulation of T cell clones and assessment of the contribution of each residue beyond this size to antigenic potency. J Immunol 135:2598, 1985
20. Murphy E, Shibuya K, Hosken N, Openshaw P, Maine V, Davis K, Murphy K, O'Garra A: Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J Exp Med 183:901, 1996
21. Wysocka M, Kubin M, Vieira LQ, Ozmen L, Garotta G, Scott P, Trinchieri G: Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol 25:672, 1995
22. Alegre M-L, Yun Tso J, Sattar HA, Smith J, Desalle F, Cole M, Bluestone JA: An anti-murine CD3 monoclonal antibody with a low affinity for Fc receptor suppresses transplantation responses while minimizing acute toxicity and immunogenicity. J Immunol 155:1544, 1995
23. Hasbold J, Johnson-Leger C, Atkins CJ, Clark EA, Klaus GG: Properties of mouse CD40: Cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies. Eur J Immunol 24:1835, 1994
24. Sornasse T, Flamand V, De Becker G, Bazin H, Tielemans F, Thielemans K, Urbain J, Leo O: Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo. J Exp Med 175:15, 1992
25. Austyn JM, Hankins DF, Larsen CP, Morris PJ, Rao AS, Roake JA: Isolation and characterization of dendritic cells from mouse heart and kidney. J Immunol 152:2401, 1994
26. Gajewski TF, Pinnas M, Wong T, Fitch FW: Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J Immunol 146:1750, 1991
27. Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh C, Culpepper JA, Wysocka M, Trinchieri G, Murphy KM, O'Garra A: Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 154:5071, 1995
28. Heufler C, Koch F, Stanzi U, Topar G, Wysocka M, Trinchiera G, Enk A, Steinman RM, Romani N, Schuler G: Interleukin-1 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol 26:649, 1996
29. Delaney VB, Campbell WG, Nasr SA, McCue PA, Warshaw B, Whelchel JD: Efficacy of OKT3 monoclonal antibody therapy in steroid-resistant, predominantly vascular acute rejection. Transplantation 45:743, 1988
30. Kreis H, Legendre C, Chatenoud L: OKT3 in organ transplantation. Transplant Rev 5:181, 1991
31. Gaston RS, Deierhoi MH, Patterson T, Prasthofer E, Julian BA, Barber WH, Laskow DA, Diethelm AG, Curtis JJ: OKT3 first dose reaction: Association with T cell subsets and cytokine release. Kidney Im 39:141, 1991
32. Roitt IM: OKT3: Immunology, production, purification, and pharmacokinetics. Clin Transplant 7:367, 1993
33. Buysmann S, Bemelman FJ, Schellekens PThA, van Kooyk Y, Figdor CG, ten Berge IJM: Activation of increased expression of adhesion molecules on peripheral blood lymphocytes is a mechanism for the immediate lymphocytopenia after administration of OKT3. Blood 87:404, 1996
34. Janssen O, Wesselborg S, Kabelitz D: Immunosuppression by OKT3-induction of programmed cell death (apoptosis) as a possible mechanism of action. Transplantation 53:233, 1992
35. Caillat-Zucman S, Blumenfeld N, Legendre C, Noel L-H, Bach J-P, Kreis H, Chatenoud L: The OKT3 immunosuppressive effect. Transplantation 49:156, 1990
36. Flamand V, Donckier V, Abramowicz D, Goldman M, Vandenabeele P, Urbain J, Moser M, Leo O: In vivo immunosuppression induced by a weakly mitogenic antibody to mouse CD3: Evidence that induction of long-lasting in vivo unresponsiveness requires TcR signaling. Cell Immunol 157:239, 1994
37. Willems F, Andris F, Xu D, Abramowicz D, Wissing M, Goldman M, Leo O: The induction of human T cell unresponsiveness by soluble anti-CD3 mAb requires T cell activation. Int Immunol 7:1593, 1995
38. Winzler C, Rovere P, Rescigno M, Granuci F, Penna G, Adorini L, Zimmermann VS, Davoust J, Ricciardi-Castagnoli P: Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med 185:317, 1997
39. De Smedt T, Pajak B. Klaus GGB, Noelle RJ, Urbain J, Leo O, Moser M: Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo. J Immunol 161:4476, 1998
40. Wissing KM, Desalle F, Abramowicz D, Willems F, Leo O, Goldman M, Alegre M-L: Down regulation of IL-2 and IFN-γ and maintenance of IL-4 and IL-10 production after administration of an anti-CD3 mAb in mice. Transplantation 68:677, 1999
41. Gilben KM, Hoang KD, Weigle WO: Th1 and Th2 clones differ in their response to a tolerogenic signal. J Immunol 144:2063, 1990
42. De Wit D, Van Mechelen M, Ryelandt M, Figueiredo AC, Abramowicz D, Goldman M, Bazin H, Urbain J, Leo O: The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes. J Exp Med 175:9, 1992
43. Birkeland SA, Bach JF, Chatenoud L, Jorgensen KA, Strate M, Elbirk A, Rohr N, Svendsen V: First and second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection followed by testing for anti-OKT3 IgM and/or IgG immunization. Transplant Proc 22:221, 1990
44. Chatenoud L: Humoral immune response against OKT3. Transplant Proc 25:68, 1993
45. 2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb. Transplantation 49:1117, 1990
46. 2 fragments induce a selective T helper dysfunction. J Immunol 147:2088, 1991
47. Woodle ES, Hussein S, Bluestone JA: In vivo administration of anti-murine CD3 monoclonal antibody induces selective, long-term anergy in CD8+ T cells. Transplantation 61:798, 1996
48. Chouaib S, Chehimi J, Bani L, Genetet N, Tursz T, Gay F, Trinchieri G, Mami-Chouaib F: Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors. Proc Natl Acad Sci USA 91:2659, 1994
49. Mehrotra PT, Wu D, Crim JA, Mostowskj HS, Siegel JP: Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes. J Immunol 151:2444, 1993
50. Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, Linsley PS, Bluestone JA: Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257:789, 1992
51. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC: Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434, 1996
52. Roberts MS, Knight SC: Low-dose immunosuppression by cyclosporin operating via antigen-presenting dendritic cells. Transplantation 50:91, 1991